Forté Pharma strengthens cosmetics range with oral supplement launch

20 Jan 2020

Reig Jofre's oral, anti-wrinkle, moisturizing and firming cosmetic expands Forté Pharma's beauty range.

Forté Pharma, Reig Jofre's line of nutritional supplements, has expanded its range of beauty products with the launch in Spain, France and Belgium of Expert Lift’ Filler, a new nutritional supplement in the form of a drinkable stick designed to reduce the volume of wrinkles and moisturize and firm the skin.

Forté Pharma strengthens cosmetics range with oral supplement launch

Scientific studies have proven and measured a reduction of wrinkle volume of up to 50% after an 8-week intake. They also confirm the effectiveness of the product’s formula, which contains a high concentration of bioactive collagen that improves skin elasticity, hyaluronic acid that contributes to the maintenance of good hydration, vitamins A, C and E, and the minerals selenium and manganese, which provide antioxidant protection and prevent skin ageing.

The oral cosmetics market is growing, representing sales of more than 25 million euros in France, a market in which Forté Pharma is among the leading companies in the sector.

Forté Pharma currently organizes its product portfolio in four ranges: beauty (13% of sales), weight control (36%), energy (27%), and health (24%) at the end of December 2019.

Read More

Related news

FDA success for MedPharm Centre of Excellence

FDA success for MedPharm Centre of Excellence

14 Feb 2020

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

Read more 
Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing

Stevanato Group partners with Pfeiffer Vacuum to deliver effective biopharma industry testing

12 Feb 2020

Partnership will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Read more 
Catalent to manufacture first-in-class mAb targeting solid tumours

Catalent to manufacture first-in-class mAb targeting solid tumours

11 Feb 2020

ZM008 could have potential benefits for the treatment of prostate cancer.

Read more 
BD completes clinical trial for its wearable injector

BD completes clinical trial for its wearable injector

11 Feb 2020

The pre-filled, pre-assembled injector is designed to prioritize safety, convenience and usability while delivering high-value drug treatments in the comfort of an in-home environment.

Read more 
Innovation awarded at Pharmapack

Innovation awarded at Pharmapack

10 Feb 2020

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Read more 
2020 - a year for 'big answers' rather than 'big data'

2020 - a year for 'big answers' rather than 'big data'

7 Feb 2020

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

Read more 
Recipharm acquisition to make it a top 5 global CDMO?

Recipharm acquisition to make it a top 5 global CDMO?

6 Feb 2020

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

Read more 
New Velesco Pharma clinical manufacturing facility begins operations

New Velesco Pharma clinical manufacturing facility begins operations

5 Feb 2020

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

Read more 
Colorcon starts No-Tox ink manufacturing at new UK facility

Colorcon starts No-Tox ink manufacturing at new UK facility

4 Feb 2020

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Read more 
Hovione announces key patent grants for its large dose DPI

Hovione announces key patent grants for its large dose DPI

4 Feb 2020

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

Read more